Caplin Point Laboratories Limited (NSE:CAPLIPOINT)
India · Delayed Price · Currency is INR 2,655.00
+40.80 (1.56%)
Jul 20, 2026, 3:30 PM IST
Caplin Point Laboratories Market Cap
Caplin Point Laboratories has a market cap or net worth of 198.69 billion as of July 20, 2026. Its market cap has increased by 24.43% in one year.
Market Cap
198.69B
Enterprise Value
189.86B
Revenue
21.87B
Ranking
n/a
PE Ratio
30.99
Stock Price
2,655.00
ChartMarket Cap Chart
Since February 26, 2002, Caplin Point Laboratories's market cap has increased from 5.60M to 198.69B, an increase of 3,548,651.09%. That is a compound annual growth rate of 53.60%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 20, 2026 | 198.69B | 41.97% |
| Dec 31, 2025 | 139.95B | -26.39% |
| Dec 31, 2024 | 190.12B | 84.60% |
| Dec 29, 2023 | 102.99B | 90.47% |
| Dec 30, 2022 | 54.07B | -16.82% |
| Dec 31, 2021 | 65.01B | 69.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gland Pharma | 403.49B |
| Emcure Pharmaceuticals | 338.08B |
| Wockhardt | 308.85B |
| Piramal Pharma | 238.12B |
| Eris Lifesciences | 201.67B |
| NATCO Pharma | 169.26B |
| Cohance Lifesciences | 169.06B |
| Alembic Pharmaceuticals | 162.18B |